文献速递肝病

237例非酒精性脂肪性肝病患者内毒素血症与组织学严重程度显著正相关

Significant positive association of endotoxemia with histological severity in 237 patients with non-alcoholic fatty liver disease.
PubMed 文献 · Aliment Pharmacol Ther · 2017-05-02

在237例非酒精性脂肪性肝病患者中,于肝活检前1天检测内毒素血症标志物脂多糖结合蛋白(LBP)和内毒素水平。LBP与NASH和F2-4纤维化相关,内毒素与纤维化相关;性别、较高BMI和糖化血红蛋白及TM6SF2变异是与LBP升高相关的独立因素。

要点

  • LBP與NASH相關(15.3±4.6 vs 13.8±3.3 μg/mL;P=.005)。
  • LBP與F2-4纖維化相關(15.4±4.4 vs 14.0±3.7 μg/mL;P=.008)。
  • TM6SF2 rs58542926 T等位基因攜帶者LBP水平更高。

核心结论

  • 内毒素血症与NASH和显著纤维化呈正相关。
  • TM6SF2与内毒素血症之间的关联需进一步研究。

研究设计与样本

  • 在237例非酒精性脂肪性肝病患者中,于肝活检前1天测量内毒素血症标志物LBP和内毒素水平。
  • 同时检测肝损伤生物标志物并进行瞬时弹性成像作为疾病严重程度的附加标志物。

主要发现

  • 114/237(48%)患者有NASH,80/237(34%)有F2-4纤维化。
  • LBP与小叶内炎症相关(P=.001),LBP(P=.0004)和内毒素水平(P=0.008)均与纤维化相关。
  • LBP与细胞角蛋白-18片段(P=.002)和天冬氨酸氨基转移酶与丙氨酸氨基转移酶比值(P=.006)相关,LBP(P=.019)和内毒素(P=.006)均与瞬时弹性成像测定的肝硬度相关。
  • NASH患者LBP升高(15.3±4.6 vs 13.8±3.3 μg/mL;P=.005),F2-4纤维化患者LBP升高(15.4±4.4 vs 14.0±3.7 μg/mL;P=.008)。
  • 携带TM6SF2 rs58542926 T等位基因(易感NAFLD/NASH)的患者LBP水平更高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth. AIM: To test the hypothesis that endotoxemia is associated with the histological severity of nonalcoholic fatty liver disease (NAFLD) and determine factors associated with endotoxemia. METHODS: The endotoxemia markers lipopolysaccharide-binding protein (LBP) and endotoxin levels were measured in 237 NAFLD patients 1 day before liver biopsy. Biomarkers of liver injury and transient elastography were performed as additional markers of disease severity. RESULTS: A total of 114/237 (48%) patients had NASH and 80/237 (34%) had F2-4 fibrosis. LBP was correlated with lobular inflammation (P=.001), while both LBP (P=.0004) and endotoxin levels (P=0.008) were correlated with fibrosis. LBP was also correlated with cytokeratin-18 fragments (P=.002) and aspartate aminotransferase-to-alanine aminotransferase ratio (P=.006), and both LBP (P=.019) and endotoxin (P=.006) were correlated with liver stiffness measurement by transient elastography. LBP was increased in patients with NASH (15.3±4.6 vs 13.8±3.3 μg/mL; P=.005) and F2-4 fibrosis (15.4±4.4 vs 14.0±3.7 μg/mL; P=.008). Interestingly, patients harbouring the TM6SF2 rs58542926 T allele that predispose to NAFLD/NASH had higher LBP level. By multivariate analysis, gender, higher body mass index and glycated haemoglobin, and TM6SF2 variants were independent factors associated with increased LBP level. CONCLUSIONS: Endotoxemia is positively associated with NASH and significant fibrosis. The association between TM6SF2 and endotoxemia warrants further investigations. The findings may shed light on the pathogenesis of NASH and inform a novel treatment target.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Pang J, Xu W, Zhang X, et al. Significant positive association of endotoxemia with histological severity in 237 patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2017. PMID: 28464257. doi:10.1111/apt.14119

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。